Medicines Optimisation

UK/PHP/13/0087May 2013

This meeting is organised and funded by Pfizer

Agenda

• Pfizer Healthy Partnerships and the Pharmacy Development Team• Medicines Optimisation definition• Patient outcomes• 2012 campaign overview and results• Medicines Optimisation future developments

• Stand out as the leadership company for pharmacy for support, knowledge and collaboration

• Demonstrate the value of pharmacy within the local and national healthcare environment

• Continue partnering to deliver positive outcomes for pharmacy and Pfizer in reputation

Pharmacy Development Team: Strategy

Medicines Optimisation - definition1

• Improving quality, value and outcomes for patients from use of their medicines

• Higher level of engagement with patients and the public• Breaking down barriers between the professions• Incorporates concordance and adherence, more sophisticated than medicines

management

Dr Keith Ridge, Chief Pharmaceutical Officer England

1. Keith Ridge; http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained, March 2013

Patient outcomes• A challenge to measure

Launched to raise awareness:• Importance of taking medicines as prescribed• Benefits to patient health• Better value for NHS• Position community pharmacists as medicines

experts• Encourage patient engagement with community

pharmacy

Medicines Optimisation Campaign (2012)

2. Medicines Optimisation poster, Pfizer data on file Sept 2012

2

Launched in two phases:• Pharmacy media and Consumer media• Print, online media, Pharmacy Show• Radio campaign• Posters• Access Pfizer

Medicines Optimisation Campaign (2012)2

2. Medicines Optimisation poster, Pfizer data on file Sept 2012

3. Regional Medicines Optimisation posters, Pfizer, data on file Sept 2012

Regional versions (England)

24medical online & print articles

12regional online

newspapers

48social media

posts

10regional radio

bulletins

3,275,481total reach

2national

consumer pieces

4. Data on file, Nov 2012

Results

• Develop a better understanding of how Medicines Optimisation can be supported by the Professional Bodies and the ABPI

• Develop a better understanding of how patient behaviour influences Medicines Optimisation

• Develop a better understanding of how Medicines Optimisation can improve patient outcomes

Medicines Optimisation future developments:

1. Keith Ridge interview, PJ online March 2013http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained2. Medicines Optimisation poster (national), Sept 20123. Medicines Optimisation posters (regional), Sept 20124. Data on file, results of media campaign, Nov 2012

• Ref quoted re £300M: Evaluation of the Scale,Causes and Costs of Waste Medicines, York Health

Econimics Consortium and School of Pharmacy, University of London, Nov 2010

References